Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1964 2
1966 1
1967 2
1969 1
1970 2
1972 2
1975 1
1976 3
1977 1
1978 5
1979 5
1980 3
1981 8
1982 5
1983 6
1984 3
1985 1
1986 5
1987 6
1988 4
1989 2
1992 1
1993 1
1994 1
1995 2
1996 1
1997 2
1998 6
1999 2
2000 1
2001 2
2002 1
2003 3
2004 3
2005 9
2006 4
2007 2
2008 2
2009 1
2013 1
2014 1
2016 1
2017 2
2018 1
2019 1
2020 2
2021 4
2023 4

Text availability

Article attribute

Article type

Publication date

Search Results

125 results

Results by year

Filters applied: . Clear all
Page 1
CT and MR imaging of cerebral tuberous sclerosis.
Inoue Y, Nemoto Y, Murata R, Tashiro T, Shakudo M, Kohno K, Matsuoka O, Mochizuki K. Inoue Y, et al. Among authors: matsuoka o. Brain Dev. 1998 Jun;20(4):209-21. doi: 10.1016/s0387-7604(98)00022-9. Brain Dev. 1998. PMID: 9661965 Review.
Safety and immunogenicity of Clostridium difficile toxoid vaccine in Japanese adults.
Matsuoka O, Patel DM, Sasaki S, Oka H, Sasaki T, Pietrobon PJ, Laot T, Bouckenooghe A, Menezes J, de Bruyn G. Matsuoka O, et al. Hum Vaccin Immunother. 2018 Feb 1;14(2):322-328. doi: 10.1080/21645515.2017.1395538. Epub 2017 Dec 6. Hum Vaccin Immunother. 2018. PMID: 29116880 Free PMC article. Clinical Trial.
Adrenoleukodystrophy: new CT findings.
Inoue Y, Fukuda T, Takashima S, Ochi H, Onoyama Y, Kusuda S, Matsuoka O, Murata R. Inoue Y, et al. Among authors: matsuoka o. AJNR Am J Neuroradiol. 1983 Jul-Aug;4(4):951-4. AJNR Am J Neuroradiol. 1983. PMID: 6410880 Free PMC article.
Safety/tolerability, efficacy and pharmacokinetics of 600-μg cotadutide in Japanese type 2 diabetes patients with a body mass index of 25 kg/m2 or higher: A phase I, randomized, double-blind, placebo-controlled study.
Asano M, Sekikawa A, Sugeno M, Matsuoka O, Robertson D, Hansen L. Asano M, et al. Among authors: matsuoka o. Diabetes Obes Metab. 2023 Aug;25(8):2290-2299. doi: 10.1111/dom.15107. Epub 2023 Jun 19. Diabetes Obes Metab. 2023. PMID: 37337366 Clinical Trial.
Superior immunogenicity of high-dose quadrivalent inactivated influenza vaccine versus Standard-Dose vaccine in Japanese Adults ≥ 60 years of age: Results from a phase III, randomized clinical trial.
Sanchez L, Nakama T, Nagai H, Matsuoka O, Inoue S, Inoue T, Shrestha A, Pandey A, Chang LJ, De Bruijn I; QHD00010 Study Group. Sanchez L, et al. Among authors: matsuoka o. Vaccine. 2023 Apr 6;41(15):2553-2561. doi: 10.1016/j.vaccine.2023.02.071. Epub 2023 Mar 10. Vaccine. 2023. PMID: 36906404 Free article. Clinical Trial.
Immunogenicity and safety of high-dose quadrivalent influenza vaccine in Japanese adults ≥65 years of age: a randomized controlled clinical trial.
Sanchez L, Matsuoka O, Inoue S, Inoue T, Meng Y, Nakama T, Kato K, Pandey A, Chang LJ. Sanchez L, et al. Among authors: matsuoka o. Hum Vaccin Immunother. 2020 Apr 2;16(4):858-866. doi: 10.1080/21645515.2019.1677437. Epub 2019 Nov 19. Hum Vaccin Immunother. 2020. PMID: 31634025 Free PMC article. Clinical Trial.
Neopterin in subacute sclerosing panencephalitis.
Shintaku H, Murata R, Hattori H, Matsuoka O, Nakajima T, Imamura T, Sawada Y. Shintaku H, et al. Among authors: matsuoka o. Adv Exp Med Biol. 1993;338:247-50. doi: 10.1007/978-1-4615-2960-6_50. Adv Exp Med Biol. 1993. PMID: 8304118 No abstract available.
Long Term Follow-Up Study of a Randomized, Open-Label, Uncontrolled, Phase I/II Study to Assess the Safety and Immunogenicity of Intramuscular and Intradermal Doses of COVID-19 DNA Vaccine (AG0302-COVID19).
Nakagami H, Matsumoto T, Takazawa K, Sekino H, Matsuoka O, Inoue S, Furuie H, Morishita R. Nakagami H, et al. Among authors: matsuoka o. Vaccines (Basel). 2023 Sep 28;11(10):1535. doi: 10.3390/vaccines11101535. Vaccines (Basel). 2023. PMID: 37896939 Free PMC article.
125 results